Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
LivaNova PLC

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

LIVN●NASDAQ
HealthcareMedical - Devices
$82.20
$3.62(4.61%)
U.S. Market opens in 3h 2m

LivaNova PLC (LIVN)

Meyka AI Score

Z

Key Financials

Market Cap4.4B
P/E Ratio23.95
EPS (TTM)$4.21
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$87.02
3 Months$100.73
1 Year Target$83.99

LIVN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of LivaNova PLC (NASDAQ: LIVN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, LivaNova PLC's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LIVN on the NASDAQ shows an RSI of 55.69, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $83.99 for the NASDAQ listing.

Key metrics behind LivaNova PLC's NASDAQ-traded stock include a P/E ratio of 23.95 and a market capitalization of 4.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LIVN on the NASDAQ.

Price Performance (NASDAQ: LIVN)

1-Day Change
1.76%
5-Day Change
8.98%
1-Month Change
-0.94%
3-Month Change
13.47%
6-Month Change
24.92%
Year-to-Date (YTD) Change
33.59%
1-Year Change
54.92%
3-Year Change
47.44%
5-Year Change
6.84%
All-Time (Max) Change
17.55%

Contact Information

https://www.livanova.com
44 20 3325 0660
20 Eastbourne Terrace, London, GL, W2 6LG

Company Facts

33,000 Employees
IPO DateOct 19, 2015
CountryGB
Actively Trading

Frequently Asked Questions